Evidence map›Paper›PMID 31674709›Full record

ArticleJournal of applied microbiology2020

Evolutionary adaptation of Aspergillus niger for increased ferulic acid tolerance.

R J M Lubbers, A J Liwanag, M Peng, A Dilokpimol, I Benoit-Gelber, R P de Vries

Open access · bronzeAbstract read
In one paragraph

Article in Journal of applied microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Utilization of ferulic acid inFrontiers in fungal biology · 2022
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

R J M LubbersFungal Physiology, Westerdijk Fungal Biodiversity Institute, Fungal Molecular Physiology, Utrecht University, Utrecht, The Netherlands.
A J LiwanagFungal Physiology, Westerdijk Fungal Biodiversity Institute, Fungal Molecular Physiology, Utrecht University, Utrecht, The Netherlands.
M PengFungal Physiology, Westerdijk Fungal Biodiversity Institute, Fungal Molecular Physiology, Utrecht University, Utrecht, The Netherlands.
A DilokpimolFungal Physiology, Westerdijk Fungal Biodiversity Institute, Fungal Molecular Physiology, Utrecht University, Utrecht, The Netherlands.
I Benoit-GelberCentre for Structural and Functional Genomics, Concordia University, Montréal, Canada.
R P de VriesFungal Physiology, Westerdijk Fungal Biodiversity Institute, Fungal Molecular Physiology, Utrecht University, Utrecht, The Netherlands.ORCID https://orcid.org/0000-0002-4363-1123
Utrecht University · NLConcordia University · US

Funding

Horizon 2020 Framework Programme 720918Seventh Framework Programme 607044Stichting voor de Technische Wetenschappen 016.130.609
6 · The paper itself

Abstract

aimsTo create an Aspergillus niger mutant with increased tolerance against ferulic acid using evolutionary adaptation. METHODS AND

resultsEvolutionary adaptation of A. niger N402 was performed by consecutive growth on increasing concentrations of ferulic acid in the presence of 25 mmol l

conclusionsThe evolutionary adaptive A. niger mutant Fa6 has beneficial mutations that increase the tolerance, conversion rate and uptake of ferulic acid. SIGNIFICANCE AND IMPACT OF THE STUDY: This study demonstrates that evolutionary adaptation is a powerful tool to modify micro-organisms towards increased tolerance to harsh conditions, which is beneficial for various industrial applications.

Indexed as

Evolution, MolecularAspergillus nigerCoumaric AcidsGene Expression ProfilingMutationCoumaric Acidsferulic acidadaptive evolutionaromatic metabolismAspergilluscell factoryferulic acid tolerancemutagenesis

Identifiers

PMID31674709
PMCPMC7027748
OpenAlexW2983200748

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.